MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2024 International Congress

    A Nomogram Model for Predicting Malnutrition among Patients with Parkinson’s Disease

    Q. Huang, X. Zou (Chengdu, China)

    Objective: This study aims to develop and validate a Nomogram prediction model for assessing malnutrition risk in PD patients. Background: Parkinson's disease (PD) is a…
  • 2024 International Congress

    Odor-specific symptoms in Parkinson’s disease – UPSIT odor identification status versus clinical severity.

    YG. Guo, SC. Chiu (Taichung, Taiwan)

    Objective: To explore correlations between the identification status of individual odors in the Pennsylvania Smell Identification Test (UPSIT) and the clinical severity of Parkinson’s disease…
  • 2024 International Congress

    Orthostatic Hypotension:a Clinical Marker for the Body-First Subtype of Patients with Parkinson’s Disease

    S. Mei, X. Wang, C. Han, P. Chan (Beijing, China)

    Objective: Our study aimed to investigate the clinical characteristics of PD patients stratified by OH status before and after levodopa challenge to explore the hypothesis…
  • 2024 International Congress

    Prevalence of Helicobacter Pylori Infection Among Nepalese Parkinson’s Disease Patients and their Clinical Manifestations

    R. Ojha, B. Gajurel, R. Karn, R. Rajbhandari, R. Hamal, A. Jha, R. Pathak (Kathmandu, Nepal)

    Objective: To know the prevalence of Helicobacter Pylori infection among Nepalese Parkinson´s Disease patients and understand their clinical characteristics Background: Helicobacter pylori (HP) is prevalent…
  • 2024 International Congress

    Clinical Predictors of Impulse Control Disorders in Parkinson’s Disease

    T. Breddy, P. Macdonald, K. van Hedger, H. Ganjavi (London, Canada)

    Objective: To investigate whether anxiety, depression, and sleep impairment relate to development of impulse control disorders (ICD) in patients with early-stage Parkinson’s disease (PD). Background:…
  • 2024 International Congress

    Longitudinal patterns of Anxiety and Depression in patients with Parkinson’s Disease

    O. Lawal, M. Morales, S. Shakya, J. Savitt, S. Reich, A. Gruber-Baldini, L. Shulman, R. von Coelln (Baltimore, USA)

    Objective: To analyze longitudinal trends of severity of anxiety and depression in a large Parkinson’s Disease (PD) cohort Background: •Depression and anxiety are common non…
  • 2024 International Congress

    Prognostic Value of Parkinson’s Disease Subtypes in the LABS-PD Cohort: Functional ability, Quality of life and Mortality

    D. Dash, S. Eberly, D. Oakes, D. Grimes, A. Lang, C. Tanner, C. Marras, T. Mestre (Ottawa, Canada)

    Objective: To assess the prognostic relevance of a data-driven PD subtyping system generated in the Longitudinal and Biomarker Studies in Parkinson’s disease study (LABS-PD) in…
  • 2024 International Congress

    Long-term Blood Pressure Measures in Incident Parkinson’s Disease in the Framingham Heart Study.

    S. O'Shea, Y. Liu, Y. Li, A. Gurnani, J. Dookhy, S. Frank, R. Au, J. Mez, T. Ang, L. Shih (New York, USA)

    Objective: To assess the relationships of long-term blood pressure (BP) measures and incident Parkinson’s disease (PD) in the Framingham Heart Study (FHS) cohort. Background: Long-term…
  • 2024 International Congress

    Validation Study of the Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest)

    V. Stopic, S. Jost, J. Haupt, G. Brandt, C. Vander Linden, JN. Petry-Schmelzer, T. Dembek, G. Fink, L. Batzu, A. Rizos, R. Chaudhuri, H. Dafsari, D. Gruber, G. Ebersbach, J. Kessler, M. Barbe, A. Sauerbier (Cologne, Germany)

    Objective: To test the psychometric properties of the newly developed Parkinson’s Disease Stigma Questionnaire (PDStigmaQuest). Background: Stigma is a significant aspect of Parkinson’s disease (PD).…
  • 2024 International Congress

    Touchscreen performance in people with Parkinson’s Disease

    N. Cohen, R. Kizony (Haifa, Israel)

    Objective: To investigate touchscreen performance and its associations with cognitive ability and upper limb (UL) function in people with Parkinson’s Disease (PWP). Background: Touchscreen use…
  • « Previous Page
  • 1
  • …
  • 46
  • 47
  • 48
  • 49
  • 50
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • An atypical and interesting feature of Parkinson´s disease
  • “Striatal Hand Signs” and early diagnosis of Parkinson's Disease: The “Monkey-Wrench Sign”.
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of Ketone Ester Supplementation on Motor and Non-Motor symptoms in Parkinson's Disease
  • An atypical and interesting feature of Parkinson´s disease
  • Yerba Mate (Ilex paraguaiensis) protects dopaminergic neurons degeneration and improve their maturation in culture
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley